News
Aromatase inhibitors, either alone or in combination with growth hormone, can boost final height in mid-pubertal boys with ...
This is the first trial to prospectively demonstrate the impact of bone-protecting agents use on fracture risk for men receiving an androgen receptor pathway inhibitor.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback